Siriraj Genomics Center aims to expand breast cancer gene testing services
In an effort to provide equal access to breast cancer screening, Siriraj Genomics Center at Faculty of Medicine Siriraj Hospital, Mahidol University, plans to expand its services. Currently, access to screening services is limited to large hospitals and medical schools, leaving many people without proper screening opportunities. Recognizing the importance of this issue, Professor Dr. Manop Pitakphakorn, Head of the Center for Excellence in Precision Medicine, stated that the screening service for breast cancer gene mutations (BRCA1/BRCA2) is included in the benefits provided by the National Health Security Office (NHSO) for all Thai citizens.
This screening service is particularly significant for Thai women who are at risk of developing breast cancer due to genetic factors or having a family history of the disease. By identifying specific genes that may mutate into cancer genes, early prevention measures can be taken, reducing the risk of breast cancer. Moreover, genetic decoding can provide valuable information to identify high-risk groups for cancer prevention strategies from birth. This data, collected through the Genomics Project of Thailand, holds great importance for future medical treatments, aiming for precision medicine.
Thailand leading in genomics services in ASEAN
Professor Dr. Manop highlighted that the screening service is made possible through the analysis of genetic decoding data obtained from Thai patients in various disease groups, including cancer, rare diseases, chronic communicable diseases, infectious diseases, and genetics pharmaceuticals. This initiative is part of the Thailand Genomics Integrated Action Plan 2020-2024, positioning Thailand as the first ASEAN country to offer accessible genomics services free of charge to all citizens. While Singapore initiated a similar project earlier, Thailand’s comprehensive healthcare progress and technological advancements have propelled the nation forward.
Despite the benefit package for breast cancer screening among at-risk groups, the accessibility of services remains limited to larger medical institutions such as hospitals and medical schools, including cancer center hospitals. Community and smaller hospitals have the potential for screening, but the absence of a clear system or process to support these institutions hinders widespread access to breast cancer screening. It is crucial to resolve these issues in order to ensure equal access throughout the country for patients and high-risk groups.
Siriraj Genomics Center Repeat breast cancer gene test prognosis dyke But admission people still have less access to screening. Even if it is a privilege by all rights. Services are still concentrated in large hospitals and medical schools, although some community hospitals have the potential to operate. But there is still no clear system to support them.
On 4 September, Professor Dr. Manop Pitakphakorn, Head of the Center for Excellence in Precision Medicine Siriraj Genomics Center Faculty of Medicine Siriraj Hospital, Mahidol University revealed that the screening service for breast cancer gene mutations (BRCA1/BRCA2) that the NHSO includes in the benefits for promoting health and disease prevention All Thai people have all rights free of charge. It is considered beneficial for Thai women at risk of such diseases and the health service system. Because most of them are caused by genetic factors or being a direct relative of a family member suffering from cancer before. Causes risk of cancer as well as up to 50%, but if screened finds out which genes are genetic and will be mutated into cancer genes to prevent it first It can help reduce the risk of breast cancer among Thai people. In addition, if it is found that there is information from genetic decoding It can make it possible to see the prevention of cancer risk groups from birth, which are all 50,000 DNA data from the Genomics Project of Thailand It is very important for medical treatment in the future. to aim for precision medicine
Prof Dr Manop said this screening service comes from analyzing data obtained from the genetic decoding of Thai people who are patients in 5 major disease groups, including cancer, rare diseases, chronic communicable diseases (NCDs), infectious diseases and genetics pharmaceuticals Under the Thailand Genomics Integrated Action Plan 2020-2024 (Thailand Genomics), which is considered one of the nation’s new medical technologies (Genomic Medicine). As a result, Thailand is the first country in ASEAN to offer genomics services accessible to all citizens. free Although it is the second country that started the project from Singapore. But it can be seen that the development and extension of medical technology has led to comprehensive health services. Thailand has made great progress.
However, now screening for breast cancer in risk groups Even if it is a benefit package. but access to services is not yet widespread Because it is still limited to large hospitals, medical schools, including cancer center hospitals, but in the case of community hospitals or small hospitals in some states, some have the potential for screening. or collect items for inspection as well But at the moment there is no clear system or process to support it. This leads to a lack of access to breast cancer screening. It is believed that there are patients and risk groups throughout the country.
#Siriraj #Genomics #Center #Emphasis #screening #breast #cancer #prognosis #people #access #rights #Community #hospitals #lack #support #systems
